NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹69 Cr | ₹73 Cr | ₹60 Cr | ₹58 Cr | ₹57 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹69 Cr |
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹57 Cr |
How is Deferred Tax Assets / Liabilities of NEULAND LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹69 Cr | -5.30 | |
| Mar2025 | ₹73 Cr | 20.49 | |
| Mar2024 | ₹60 Cr | 3.67 | |
| Mar2023 | ₹58 Cr | 2.82 | |
| Mar2022 | ₹57 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,211.9 Cr | 0.6% | -9.1% | 19.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.6% |
-9.1% |
19.7% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses